avapritinib
blueprint medicines,illumina
['pathfinder', 'grail']
can multi cancer early detection work dr. deborah schragg presents pathfinder trial 121 cancer dx , 86 neg on trial - #worktodo #aacr23 
Chief of Research and Immunotherapy  •  ImmunoOncology  •  Phase I  Clinical Trials  •  Melanoma  •  Cutaneous Oncology